#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chondrodystrophy Endocrine ophthalmopathy Neoplasm malignant Chronic graft versus host disease Liver abscess Colon cancer Adenoid cystic carcinoma Arterial tortuosity syndrome Exudative retinopathy Bone marrow disorder Glioblastoma Adult T-cell lymphoma/leukaemia refractory Squamous cell carcinoma of the cervix Short stature homeobox gene mutation Becker's muscular dystrophy More trials…

    Learn about Rare Diseases

    Loeys-Dietz syndrome Antithrombin III deficiency Mitochondrial myopathy – Life with Disease Pleomorphic leiomyosarcoma Waldenstrom’s macroglobulinaemia recurrent – Basic Information Usher’s syndrome – Basic Information Shprintzen-Goldberg syndrome – Trials in Disease Small intestine leiomyosarcoma – Diagnostics Brain stem glioma – Treatment Primary mediastinal large B-cell lymphoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Solrikitug Gemlapodect Ziclumeran M2Rlab Ly3556050 Cctx-001 Ebastine Marstacimab Ascorbic Acid Cevostamab Sasanlimab F770/05 Oxymetazoline Hydrochloride Alectinib Munc-Cd34 Teclistamab Sodium Iodide (131I) Rbl012.2 Ep0042 Rilpivirine More therapies…

    Learn about Your Condition

    Glomerulonephritis chronic Intermittent claudication Biliary tract disorder Primary amyloidosis Merycism Uterine leiomyosarcoma Breast proliferative changes Myopia Subarachnoid haemorrhage Catatonia Ependymoma Systemic infection Testicular germ cell tumour Colorectal cancer stage IV Right ventricular dysfunction More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A study to evaluate the safety and effectiveness of AZD9750 and saruparib in patients with metastatic prostate cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    Investigated Drugs:
    • Saruparib
    The Netherlands Spain

  • A study to evaluate the efficacy and safety of vixarelimab in patients with moderate to severe ulcerative colitis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Vixarelimab
    • Mercaptopurine
    • Methotrexate Sodium
    Belgium Czechia France Germany Greece Italy +1

  • Study of Tarlatamab and Durvalumab compared to Durvalumab alone for patients with extensive stage small cell lung cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Argipressin
    • Mannitol
    • Siltuximab
    Austria Belgium Bulgaria Czechia Denmark France +10

  • A Study to Evaluate the Safety and Effectiveness of Ritlecitinib Tosilate in Adults with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    2 1
    Germany Greece Poland Spain

  • Phase III Study of the Efficacy and Safety of Fenebrutinib Compared with Teriflunomide in Adult Patients with Relapsing Multiple Sclerosis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Fenebrutinib
    • Teriflunomide
    Austria Bulgaria Denmark France Greece Italy +1

  • A study to compare how asundexian is absorbed in healthy adults using different formulations and the effect of food for the prevention of blood clots.

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Embolism
    Investigated Drugs:
    • Asundexian
    Germany
Previous Page
1 … 916 917 918 919 920 … 1,674
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!